By: James A. Wolff, Esq. and David Egozi
For more than four decades, the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs have served as the federal government’s primary vehicles for channeling research and development funding to small businesses. Created in 1982 (SBIR) and later expanded with the STTR program in 1992, these initiatives were designed to bridge a persistent gap in the innovation ecosystem: the difficulty small firms face in accessing early-stage capital for high-risk, high-reward technological research. By requiring federal agencies with significant research budgets to allocate a portion of their funding to small businesses, SBIR and STTR have helped launch startups, support the commercialization of emerging technologies, and strengthen U.S. technological competitiveness.
Over time, these programs have evolved from niche funding mechanisms into a well-recognized part of the startup landscape, particularly in sectors like defense, energy, and software. That continued relevance is reflected in the latest reauthorization effort. Congress introduced the Small Business Innovation and Economic Security Act (S. 3971) on March 3, 2026, following months of committee-driven negotiations over program reform, national security concerns, and commercialization bottlenecks. Signed into law on April 13, 2026, the legislation does more than extend SBIR/STTR through 2031; it signals continued federal commitment to early-stage innovation.
Eligibility, Ownership, and Foreign Influence
One of the most consequential developments in the reauthorization is the expansion of scrutiny around foreign ownership and influence. Historically, eligibility for SBIR/STTR participation has required that a company be majority owned and controlled by U.S. persons or qualifying small business concerns. The 2026 legislation builds on prior reforms by enhancing disclosure obligations and introducing more robust review mechanisms focused on national security considerations.
Participating agencies, particularly those in the defense and energy sectors, now have broader authority to assess whether foreign affiliations, investment relationships, or licensing arrangements create unacceptable risk profiles. This includes not only direct ownership stakes but also contractual relationships, joint ventures, and access rights that could implicate sensitive technologies. For venture-backed startups, this creates a tension that must be actively managed: while foreign capital may be a meaningful source of growth funding, it can also complicate or foreclose access to SBIR/STTR awards if not properly structured.
From a legal perspective, companies should conduct early-stage diligence on their capitalization tables, investor rights, and governance structures. This includes evaluating whether protective provisions, information rights, or board representation held by foreign investors could be perceived as conferring “control” or undue influence. Remedial steps, such as ring-fencing sensitive subsidiaries or restructuring investor rights, may be necessary to preserve eligibility.
Intellectual Property and Data Rights
SBIR/STTR funding has long been accompanied by unique intellectual property (IP) protections, including government use rights and limited data rights periods. The reauthorization reinforces these protections but also underscores the importance of proper documentation and compliance in maintaining them.
Under the SBIR/STTR framework, awardees typically retain ownership of inventions developed with program funding, while granting the federal government a nonexclusive license for governmental purposes. In addition, technical data generated during performance is generally protected from public disclosure for a defined period, during which agencies are restricted from sharing it outside the government.
However, these protections are not self-executing. Companies must properly mark data, adhere to contractual requirements, and ensure that internal IP assignment agreements clearly vest ownership in the entity receiving the award. Failure to follow these formalities can result in forfeiture or dilution of valuable rights.
The introduction of Strategic Breakthrough Awards and other commercialization-focused mechanisms further elevates the importance of IP strategy. As companies move closer to deployment and integration with government systems or prime contractors, negotiating licensing terms, protecting background IP, and avoiding inadvertent assignment provisions become critical. Startups should align their IP strategy with both their SBIR/STTR participation and their long-term commercialization goals, particularly where follow-on contracts or acquisitions are anticipated.
